Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pabst

Showing results (121-130 of 332) with videos related to

Pageof 34
Sort By:
Leukemia Research|April 21, 2015
Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatmentSandra Keller, Katja Seipel, Urban Novak, et al.
Critical Care Explorations|October 15, 2021
Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in SwitzerlandAnna Sarah Messmer, Yok-Ai Que, Christoph Schankin, et al.
Transfusion|September 12, 2018
Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemiaLaura C Alva, Ulrike Bacher, Katja Seipel, et al.
Biomolecules|February 25, 2023
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment OutcomeTim Lakomy, Dilara Akhoundova, Henning Nilius, et al.
Case Reports in Oncology|October 30, 2024
Therapy-Related Acute Myeloid Leukemia after CAR-T Cell Therapy with Brexucabtagene Autoleucel for Mantle Cell LymphomaFrançois Volery, Yara Banz, Alexander Heini, et al.
Cancers|December 10, 2021
Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL PatientsAnna Nydegger, Urban Novak, Marie-Noëlle Kronig, et al.
Hematological Oncology|August 3, 2022
Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patientsMelanie Maechler, Ulrike Bacher, Michael Daskalakis, et al.
British Journal of Haematology|September 13, 2014
Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemiaDana Wetzel, Beatrice U Mueller, Behrouz Mansouri Taleghani, et al.
Hematological Oncology|July 20, 2025
Elranatamab for Relapsed/Refractory Multiple Myeloma With Severe Renal Impairment Requiring HemodialysisMichèle Hoffmann, Barbara Jeker, Uyen Huynh-Do, et al.
Cancers|May 14, 2025
Prognostic Value of Post-Transplant MRD Negativity in Standard Versus High- and Ultra-High-Risk Multiple Myeloma PatientsLea Jasmin Kündgen, Dilara Akhoundova, Michele Hoffmann, et al.
Pageof 34

Showing results (121-130 of 332) with videos related to

Sort By:
Pageof 34
Leukemia Research|April 21, 2015
Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatmentSandra Keller, Katja Seipel, Urban Novak, et al.
Critical Care Explorations|October 15, 2021
Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in SwitzerlandAnna Sarah Messmer, Yok-Ai Que, Christoph Schankin, et al.
Transfusion|September 12, 2018
Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemiaLaura C Alva, Ulrike Bacher, Katja Seipel, et al.
Biomolecules|February 25, 2023
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment OutcomeTim Lakomy, Dilara Akhoundova, Henning Nilius, et al.
Case Reports in Oncology|October 30, 2024
Therapy-Related Acute Myeloid Leukemia after CAR-T Cell Therapy with Brexucabtagene Autoleucel for Mantle Cell LymphomaFrançois Volery, Yara Banz, Alexander Heini, et al.
Cancers|December 10, 2021
Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL PatientsAnna Nydegger, Urban Novak, Marie-Noëlle Kronig, et al.
Hematological Oncology|August 3, 2022
Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patientsMelanie Maechler, Ulrike Bacher, Michael Daskalakis, et al.
British Journal of Haematology|September 13, 2014
Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemiaDana Wetzel, Beatrice U Mueller, Behrouz Mansouri Taleghani, et al.
Hematological Oncology|July 20, 2025
Elranatamab for Relapsed/Refractory Multiple Myeloma With Severe Renal Impairment Requiring HemodialysisMichèle Hoffmann, Barbara Jeker, Uyen Huynh-Do, et al.
Cancers|May 14, 2025
Prognostic Value of Post-Transplant MRD Negativity in Standard Versus High- and Ultra-High-Risk Multiple Myeloma PatientsLea Jasmin Kündgen, Dilara Akhoundova, Michele Hoffmann, et al.
Pageof 34